MedDataX Logo

Evaluation of Some Trace Elements in Follicular Fluid in ICSI Cases and Their Effect on ICSI Outcomes

NCT ID: NCT06719817

Last Updated: 2024-12-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

154 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-11-24

Study Completion Date

2026-09-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To evaluate concentrations of some trace elements in the follicular fluid and their reproductive outcomes.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

To evaluate some trace elements in the follicular fluid and their reproductive outcome

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Good Responders According to Guidelines Who Wre Charectarized by AMH>0.8ng/dl Trace Elements in ICSI Cases

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Inclusion Criteria:good responders according to NICE guidelines with AMH more than 0.

Exclusion Criteria

8ng/dl and antral follicular count more than 4 Exclusion Criteria:Poor responders according to ESHRE guidelines as advanced maternal age poor ovarian response and according to NICE guidelines AMH less than 0.8ng/dl
Minimum Eligible Age

25 Years

Maximum Eligible Age

40 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Assiut University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Fatma Ahmed Saad Waley

Doctor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Faculty of medicine

Asyut, Egypt, Egypt

Site Status RECRUITING

Faculty of medicine

Asyut, Egypt, Egypt

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Fatma Ahmed Waley

Role: CONTACT

Phone: 01064402617

Email: [email protected]

Ahmed Mohammed Nasr

Role: CONTACT

Phone: 01012588888

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Ahmed Nabil Hassan

Role: primary

Ahmed Mohammed Nasr, Prof

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

AssiutU WHH

Identifier Type: -

Identifier Source: org_study_id